Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID
· Real-Time Price · USD
0.30
0.01 (4.90%)
At close: May 14, 2025, 3:58 PM
0.29
-0.17%
After-hours: May 14, 2025, 04:00 PM EDT
Ovid Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|
| License Revenue | 1.5M | 12.38M |
| License Revenue Growth | -87.86% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.9M | 5.54M | 8.1M | 7.13M | 7.39M | 6.8M | 8.25M | 8.34M | 6.67M | 7.63M | 8.26M | 9.88M | 8.26M | 6.76M | 6.63M | 15.58M | 10.41M | 7.44M | 7.11M | 5.67M | 5.16M | 5.17M | 4.2M | 4.72M | 4.5M | 4.63M | 5.09M | 4.96M | 4.33M | 3.51M | 4.21M | 2.98M | 3.6M | 3.12M | 3.65M | 2.59M | 2.21M |
| Selling, General, and Administrative Revenue Growth | -11.56% | -31.59% | +13.61% | -3.45% | +8.57% | -17.50% | -1.14% | +25.01% | -12.56% | -7.57% | -16.43% | +19.57% | +22.15% | +2.04% | -57.44% | +49.62% | +39.88% | +4.69% | +25.40% | +9.81% | -0.10% | +22.91% | -10.84% | +4.69% | -2.73% | -9.07% | +2.79% | +14.31% | +23.50% | -16.69% | +41.48% | -17.23% | +15.47% | -14.54% | +40.88% | +17.13% | n/a |
| Research and Development Revenue | 5.83M | 7.86M | 12.58M | 10.3M | 10.54M | 5.33M | 6M | 6.62M | 5.55M | 5.18M | 6.05M | 7.83M | 18.09M | 4.92M | 7.68M | 16.25M | 16.88M | 15.88M | 16.03M | 14.63M | 12.11M | 11.6M | 9.12M | 9.34M | 8.62M | 8.54M | 8.12M | 8.47M | 6.71M | 5.9M | 6.07M | 31.28M | 3.99M | 2.7M | 1.77M | 1.13M | 1.14M |
| Research and Development Revenue Growth | -25.75% | -37.57% | +22.20% | -2.32% | +97.66% | -11.11% | -9.32% | +19.29% | +6.98% | -14.28% | -22.80% | -56.70% | +267.87% | -36.00% | -52.71% | -3.76% | +6.35% | -0.98% | +9.62% | +20.82% | +4.38% | +27.20% | -2.35% | +8.30% | +0.90% | +5.28% | -4.23% | +26.24% | +13.79% | -2.89% | -80.58% | +683.91% | +47.87% | +52.46% | +57.13% | -1.13% | n/a |
| Sales and Marketing Revenue | 29K | n/a | n/a | -35K | -301K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | n/a | n/a | -100.00% | -88.37% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |